FINWIRES · TerminalLIVE
FINWIRES

TYO:8283

4 stories mentioning TYO:8283Updated 16d ago

Every FINWIRES story that references TYO:8283, newest first.

Asia

MediPal Lifts Profit Forecasts for Fiscal Year Ending March 2027

MediPal (TYO:7459) raised its attributable profit forecast for the fiscal year ending March 31, 2027, to 43 billion yen from 39 billion yen following the completion of the tender offer for Paltac's (TYO:8283) shares.The pharmaceutical wholesaler lifted its earnings per share estimate to 210.06 yen from 190.52 yen, while net sales remain unchanged at 3.944 trillion yen.The revision follows the completion of Medipal's tender offer for Paltac on July 7, with squeeze-out procedures expected around August to make Paltac a wholly owned subsidiary.As a result, profits previously attributed to non-controlling interests will now accrue entirely to Medipal.

TYO:7459TYO:8283
Asia

MediPal Raises Dividend Forecasts for Fiscal Year Ending March 2027

MediPal (TYO:7459) raised its interim and final dividend forecasts for the fiscal year ending March 31, 2027, to 44 yen each, from 34 yen previously, following the completion of the tender offer for Paltac's (TYO:8283) shares.The revised annual dividend of 88 yen per share is higher than the 66 yen per share paid in the prior fiscal year, according to a Tokyo bourse filing on Tuesday.The dividend is payable from retained earnings, with specific payment dates to be determined.The company's basic policy targets enhancing shareholder returns based on improved profit levels following the transition of Paltac into a wholly owned subsidiary.

TYO:7459TYO:8283
Asia

Japanese Shares Rise as US, Japan Reaffirm FX Coordination

Japanese shares closed higher on Tuesday after comments from U.S. Treasury Secretary Scott Bessent eased concerns over sharp currency swings, with investors taking comfort from continued coordination between Washington and Tokyo on foreign exchange stability.The Nikkei 225 rose 0.52%, or 324.69 points, to close at 62,742.57.U.S. Treasury Secretary Scott Bessent said on X that the U.S. and Japan reaffirmed their strong economic partnership and maintained close coordination on excessive currency volatility.Japanese Finance Minister Satsuki Katayama said both sides confirmed Japan's response to exchange-rate moves aligned with a bilateral agreement reached last September that permits intervention during periods of sharp market swings. Katayama said the two countries agreed to continue coordinating closely on market developments, including foreign exchange moves.In economic news, Japan's trade deficit narrowed to 224.8 billion yen in the first 20 days of April as export growth outpaced imports.Japan's foreign reserves rose by $8.25 billion in April to $1.383 trillion, supported by gains in securities and gold holdings. Meanwhile, Japan's household spending fell in March despite continued income growth, with real consumption expenditures down 2.9% from a year earlier.On the corporate front, Kawasaki Heavy Industries (TYO:7012) rose 7% after full-year profit beat guidance and the company forecast higher earnings and revenue for fiscal 2027.Mani (TYO:7730) fell 2% after receiving 2.216 billion yen in dividends from three overseas subsidiaries under its global cash management strategy.MediPal Holdings (TYO:7459) gained 1% after launching a 6,650 yen-per-share tender offer to acquire the remaining stake in Paltac (TYO:8283) and make it a wholly owned subsidiary.

Nikkei 225TYO:7012TYO:7459TYO:7730TYO:8283
Asia

Medipal Launches Tender Offer for Paltac

MediPal Holdings (TYO:7459) has launched a tender offer to acquire full ownership of Paltac (TYO:8283), aiming to make the company a wholly owned subsidiary, according to a Tuesday filing on the Tokyo Stock Exchange.The offer price is set at 6,650 yen per share, with the purchase period running from May 12 to July 7. The deal does not include a maximum acquisition limit, but sets a minimum threshold of 8.68 million shares to proceed.Medipal, which already holds about 52.4% of Paltac, said the transaction is intended to consolidate ownership and strengthen group-wide distribution capabilities across pharmaceuticals, cosmetics and daily goods.Paltac's board has expressed support for the offer and recommended that shareholders tender their shares.If completed, Medipal plans to carry out a squeeze-out process to acquire the remaining shares and delist Paltac, making it fully owned by the group. The company said it intends to finance the transaction through bank loans.

TYO:7459TYO:8283

Track with the FINWIRES app suite